A ‘historic’ FDA clearance raises the question: Is the LLM an interface or the decision-maker? UpDoc’s CEO wouldn’t say whether generative AI in the company’s diabetes app makes treatment decisions

https://www.statnews.com/2026/07/02/fda-clearance-raises-questions-updoc-use-generative-ai-diabetes-treatment/ By Mario AguilarJuly 2, 2026 Health Tech Correspondent

A year after distressed buyout, what’s become of Bluebird Bio? CEO David Meek says the company, now called Genetix, is leading in sickle cell gene therapy

https://www.statnews.com/2026/07/02/genetix-david-meek-bluebird-bio-turnaround-effort/ By Jason MastJuly 2, 2026 General Assignment Reporter

A former AI regulator, now in industry, says biopharma is reading FDA’s guidance wrong Tala Fakhouri blames both companies and the FDA for creating unnecessary hurdles

https://www.statnews.com/2026/07/02/fda-ai-guidance-pharma-industry-caution-tala-fakhouri-explains/ By Brittany TrangJuly 2, 2026 Health Tech Reporter

CDC leadership continues to try to manufacture a scientific debate on vaccines where none exists A recent seminar on vaccine effectiveness offers a warning

https://www.statnews.com/2026/07/02/measuring-vaccine-effectiveness-test-negative-design-cdc/ By Ben LopmanJuly 2, 2026 Lopman is professor of epidemiology and global health at Emory University’s Rollins School of Public Health.

U.S. judge blocks Colorado’s first-of-its-kind price cap on an Amgen drug Drugmaker was ‘likely to be significantly harmed’ by the payment limit placed on Enbrel

https://www.statnews.com/pharmalot/2026/07/02/judge-blocks-colorado-price-cap-on-amgen-enbrel/ By Ed SilvermanJuly 2, 2026 Pharmalot Columnist, Senior Writer

Up and down the ladder: The latest comings and goings By Ed SilvermanJuly 2, 2026 Pharmalot Columnist, Senior Writer

https://www.statnews.com/pharmalot/2026/07/02/pharma-biotech-jobs-ladder-vertex-gilead-astrazeneca-lilly/

Medicare takes another swing at 340B cuts to hospitals The proposal would effectively transfer funds from safety-net facilities to for-profit hospitals, advocates say

https://www.statnews.com/2026/07/02/medicare-hospital-payment-340b-drugs-cut/ By Tara BannowJuly 2, 2026 Hospitals and Insurance Reporter